The pharma and biotech industries are constantly on the lookout for services that can be integrated across the continuum of drug discovery and development needs. Wipro uses its Digital R&D Lab platform to co-create with regulators, academia and corporate partners.  These contract research services are reliable and consistent as they develop deeper, longer-lasting relationship with their sponsors, delivering speed across geographies. This pharma lab as-a-service offering combines rich domain consulting expertise and cutting-edge technology expertise to fuel the innovation engine delivering precision medicine while lowering the overall cost of drug discovery and development. The GMO & genetic testing services and microbiology lab are fuelled by experienced researchers certified in lab automation technologies (LabWare, LabVantage, IDBS, Genedata, Thermo, Waters, PE and Biovia) and customized LIMS software to ensure your products meet the appropriate national and international controls.

Wipro’s Life Sciences experts are leveraging proprietary tools and digital strength to develop voice assistance solution for labs using Virtual Personal Assistant, IoT based Smart iConnect to monitor lab assets and Digital Twin for laboratory inventory, process orchestration and experiment planning.

Partnerships

Wipro works with Xybion, a laboratory software provider with digital solutions for modern pre-clinical, analytical, quality check and process sciences laboratories, and brings systems development and platform engineering solutions at scale. In the current context, Xybion and Wipro have the ability to jointly offer an employee health and safety solution.

Collaborating with NNIT, a software Integrator, Wipro provides professional services to Life Sciences clients for lab automation solution development, project management, validation testing, platform integration, OCM and more.

By associating with MarkLogic, a data analytics company, Wipro is enabling R&D, supply chain, pharmacovigilance, and real world evidence generation— to swiftly ingest, access and achieve insights from all of their pharmaceutical data.

Wipro’s own innovation ecosystem is leveraging the Topcoder crowdsourcing program to bring bio-medical research solutions to its customers. Some promising examples include - using AI to delineate cancerous lung tumours with Harvard University to impact millions of lives, working with Pfizer to create AI based models enabling genome wide association studies to help identify new therapeutic targets and support stratification of patients that would gain the largest benefit, and working with Harvard University to deliver precision medicine solutions by developing computational biology algorithms.